Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1873003rdf:typepubmed:Citationlld:pubmed
pubmed-article:1873003lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:1873003lifeskim:mentionsumls-concept:C0006938lld:lifeskim
pubmed-article:1873003lifeskim:mentionsumls-concept:C0136123lld:lifeskim
pubmed-article:1873003lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:1873003lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1873003lifeskim:mentionsumls-concept:C0489665lld:lifeskim
pubmed-article:1873003lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:1873003pubmed:issue6lld:pubmed
pubmed-article:1873003pubmed:dateCreated1991-9-24lld:pubmed
pubmed-article:1873003pubmed:abstractTextUsing digitized M-mode echocardiograms, we compared, in a double-blind study, the effects of 4 to 8 mg perindopril given once daily and 25 to 50 mg captopril given twice daily on the left ventricle (LV) in 20 hypertensive patients. Both treatments significantly (P less than .001) lowered blood pressure, reducing systemic vascular resistances. After 3 months both drugs induced a comparable percentage of reduction in LV mass, with an increase in the peak rate of LV relaxation and no changes in the peak rate of LV contraction. Our results demonstrate that perindopril once daily is an effective antihypertensive agent; it is also able, like captopril, to induce regression of LV hypertrophy, with improvement in diastolic performance and no deterioration in ventricular systolic function.lld:pubmed
pubmed-article:1873003pubmed:languageenglld:pubmed
pubmed-article:1873003pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1873003pubmed:citationSubsetIMlld:pubmed
pubmed-article:1873003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1873003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1873003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1873003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1873003pubmed:statusMEDLINElld:pubmed
pubmed-article:1873003pubmed:monthJunlld:pubmed
pubmed-article:1873003pubmed:issn0895-7061lld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:MarchesiEElld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:FinardiGGlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:VencoAAlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:BarzizzaFFlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:PeraniGGlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:PetruccoOOlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:ScalisiBBlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:GrandiA MAMlld:pubmed
pubmed-article:1873003pubmed:authorpubmed-author:FolinoPPlld:pubmed
pubmed-article:1873003pubmed:issnTypePrintlld:pubmed
pubmed-article:1873003pubmed:volume4lld:pubmed
pubmed-article:1873003pubmed:ownerNLMlld:pubmed
pubmed-article:1873003pubmed:authorsCompleteYlld:pubmed
pubmed-article:1873003pubmed:pagination516-20lld:pubmed
pubmed-article:1873003pubmed:dateRevised2009-2-24lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:meshHeadingpubmed-meshheading:1873003-...lld:pubmed
pubmed-article:1873003pubmed:year1991lld:pubmed
pubmed-article:1873003pubmed:articleTitleDouble-blind comparison of perindopril and captopril in hypertension. Effects on left ventricular morphology and function.lld:pubmed
pubmed-article:1873003pubmed:affiliationDepartment of Internal Medicine and Medical Therapy, University of Pavia, Italy.lld:pubmed
pubmed-article:1873003pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1873003pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1873003pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1873003pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1873003lld:pubmed